CORC

浏览/检索结果: 共2条,第1-2条 帮助

限定条件        
已选(0)清除 条数/页:   排序方式:
Anlotinib versus sunitinib as first line treatment for metastatic renal cell carcinoma (mRCC): Preliminary results from a randomized phase II clinical trial 会议论文
JOURNAL OF CLINICAL ONCOLOGY, 2016-05-20
作者:  Zhou, Ai-Ping;  Ma, Jianhui;  Bai, Yuxian;  Song, Yan;  Li, Hangzhong
收藏  |  浏览/下载:7/0  |  提交时间:2020/01/04
Anlotinib in metastatic renal cell carcinoma (mRCC) with a previous anti-VEGFR TKI: Preliminary results from a multicenter, phase II trial. 会议论文
JOURNAL OF CLINICAL ONCOLOGY, 2016-05-20
作者:  Zhou, Ai-Ping;  Bai, Yuxian;  Song, Van;  Li, Hangzhong;  Xie, Xiaodong
收藏  |  浏览/下载:3/0  |  提交时间:2020/01/04


©版权所有 ©2017 CSpace - Powered by CSpace